Genmab A/S (GMAB)
34.35
+1.33
(+4.03%)
USD |
NASDAQ |
Aug 25, 16:00
34.35
0.00 (0.00%)
After-Hours: 19:59
Genmab Shareholders Equity (Quarterly) : 5.957B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.957B |
| March 31, 2026 | 5.682B |
| December 31, 2025 | 5.847B |
| September 30, 2025 | 5.751B |
| June 30, 2025 | 5.302B |
| March 31, 2025 | 5.296B |
| December 31, 2024 | 5.096B |
| September 30, 2024 | 4.779B |
| June 30, 2024 | 4.451B |
| March 31, 2024 | 4.705B |
| December 31, 2023 | 4.684B |
| September 30, 2023 | 4.417B |
| June 30, 2023 | 4.213B |
| March 31, 2023 | 3.966B |
| December 31, 2022 | 3.915B |
| September 30, 2022 | 3.512B |
| June 30, 2022 | 3.442B |
| March 31, 2022 | 3.398B |
| December 31, 2021 | 3.394B |
| September 30, 2021 | 3.317B |
| June 30, 2021 | 3.230B |
| March 31, 2021 | 3.176B |
| December 31, 2020 | 3.143B |
| September 30, 2020 | 2.911B |
| June 30, 2020 | 2.693B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.117B |
| December 31, 2019 | 2.110B |
| September 30, 2019 | 1.827B |
| June 30, 2019 | 1.264B |
| March 31, 2019 | 1.222B |
| December 31, 2018 | 1.228B |
| September 30, 2018 | 1.103B |
| June 30, 2018 | 1.075B |
| March 31, 2018 | 1.076B |
| December 31, 2017 | 1.012B |
| September 30, 2017 | 868.47M |
| June 30, 2017 | 834.41M |
| March 31, 2017 | 720.03M |
| December 31, 2016 | 684.68M |
| September 30, 2016 | 593.74M |
| June 30, 2016 | 559.76M |
| March 31, 2016 | 538.59M |
| December 31, 2015 | 507.54M |
| September 30, 2015 | 454.75M |
| June 30, 2015 | 413.67M |
| March 31, 2015 | 372.07M |
| December 31, 2014 | 330.36M |
| September 30, 2014 | 328.13M |
| June 30, 2014 | 321.46M |
| March 31, 2014 | 325.66M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -5.935B |
| Ascendis Pharma A/S | 1.642B |
| Zealand Pharma A/S | 2.753B |
| Bavarian Nordic A/S | 2.022B |
| Evaxion AS | 9.531M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.51B |
| Total Liabilities (Quarterly) | 6.558B |
| Debt to Equity Ratio | 0.8852 |
| Current Ratio | 2.457 |
| Net Debt Paydown Yield | -6.26% |